IP Library Granted Patent US 8,912,247
Granted Patent B2
US 8,912,247 · App. 11/912,188 · Granted Dec 16, 2014

Hydrophilic/hydrophobic polymer networks based on poly(caprolactone fumarate), poly(ethylene glycol fumarate), and copolymers thereof

Inventors: Shanfeng Wang (Knoxville, TN); Lichun Lu (Rochester, MN); Michael J. Yaszemski (Rochester, MN)
Assignee: Mayo Foundation for Medical Education and Research
C08G63/676A61L24/046C08G63/60C08G63/83A61L27/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,912,247
App. No.
11/912,188
Granted
Dec 16, 2014
Kind
B2
Abstract

Improved methods for preparing polyethylene glycol fumarate) are disclosed. Methods for chemically crosslinking or photocross-linking hydrophilic polyethylene glycol fumarate) with hydrophobic polymers such as poly(propylene fumarate) (PPF) and poly(caprolactone fumarate) (PCLF) to form various hydrogels (FIG. 1 ) with controllable hydrophilicity are also disclosed. The hydrogels are useful in the fabrication of injectable and in-situ hardening scaffolds for application in skeletal reconstruction. An injectable material including the hydrogels may be useful in controlled drug release.

Claims (20)

1. A crosslinkable, biodegradable material comprising:

a copolymer comprising:

poly(ethylene glycol fumarate) and

poly(caprolactone fumarate), wherein at least one of the poly(ethylene glycol fumarate) or the copolymer is prepared in the presence of potassium carbonate; and

a free radical initiator or photoinitiator;

wherein the swelling ratio of the material in water or organic solvents is controllable, and the swelling ratio of the material in water is at least about 100% after about 10 minutes of immersion in water.

2. The material of claim 1 wherein:

the material is self-crosslinkable.

3. The material of claim 1 wherein:

wherein the material is an injectable bone substitute.

4. The material of claim 1 further comprising:

a porogen.

5. The material of claim 1 further comprising:

an accelerator.

6. The material of claim 1 wherein:

the material does not include a crosslinking agent.

7. The material of claim 1 further comprising:

particulate or fiber reinforcement materials.

8. The material of claim 1 further comprising:

a bioactive agent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2014
From: WANG, SHANFENG; LIU, LICHUN; YASZEMSKI, MICHAEL J.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 032706/0615 →
CONFIRMATORY LICENSE Recorded Sep 9, 2008
From: MAYO FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021501/0207 →
Continuity (2)
Provisional Application 60676158 · Apr 29, 2005
Related Publication 20080262102A1 · Oct 23, 2008